Suvera

Primary contact
69 Old Broad St
EC2M 1QS London
United Kingdom
02038825131
69 Old Broad St
EC2M 1QS London
United Kingdom
02038825131
Funding π°
Total Β£5M
Last round π Seed
July 28, 2022.
July 28, 2022.
Select investors Ascension, Google for Startups, Morningside Group, Calm/Storm Ventures
Key people π§βπ€βπ§
- Ivan Beckley - Co-founder & CEO
- Will Gao - Co-founder & COO
- Ryzard Akita - Co-founder & Design Director
Highlights β
- Solving a problem: According to Suvera, 12% of GP appointments in the UK are dedicated to managing high blood pressure patients. The company says that up to 70% of patients who used the service were using it for blood pressure purposes, freeing GP's time for other patients.
- Easy to use: Suvera makes it easy for patients to look after their health from home or anywhere else in the world. Its patient app makes it simple for patients to share information with Suvera, and the appointments will all take place over the phone or by video call.
- Fast growth: As of July 2022, the startup has signed deals with over 40 GPs covering more than 20,000 patients since its founding in 2019.
- Highly rated: 89% of patients would recommend Suvera to a family or friend. Also, they received 4.5 out of 5 ratings from patients using their Virtual Clinic.
Quotes π¬
“
At Morningside, we invest in companies that leverage technology to both improve outcomes and reduce the cost of care at scale. We are proud to continue supporting Suvera in its mission to empower GP practices with powerful chronic condition management tools as they expand across the UK.
— Stephen Bruso, Morningside Ventures π
Last update: April 15, 2023
Disclaimer: We can not guarantee that the information on this page is 100% correct. more